BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15269151)

  • 1. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
    Spinola M; Pedotti P; Dragani TA; Taioli E
    Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
    Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
    Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S allele of the L-myc oncogene is associated with lung cancer metastases in patients from Moldova].
    Chernitsa OI; Togo AV; Shutkin VA; Khanson KP; Imianitov EN
    Vopr Onkol; 1998; 44(1):33-6. PubMed ID: 9578728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-myc gene polymorphism and risk of thyroid cancer.
    Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
    Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
    Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
    Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
    Suzuki H; Yamashiro K
    Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
    Hu Z; Wei Q; Wang X; Shen H
    Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.
    Gervasini G; Carrillo JA; Garcia M; San Jose C; Cabanillas A; Benitez J
    Cancer; 2006 Dec; 107(12):2850-7. PubMed ID: 17120199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
    Li H; Hao X; Zhang W; Wei Q; Chen K
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer.
    Marín MS; López-Cima MF; García-Castro L; Pascual T; Marrón MG; Tardón A
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1788-93. PubMed ID: 15533908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
    Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.